Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Jedd Wolchok

Tracked across 1 events · 126 articles · First seen Aug 19, 2026 · Last active Aug 26, 2026

Sentiment
60
Attention
7
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
7 60
Tech
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy Pembrolizumab, met its primary and secondary endpoints in a Phase 3 trial involving 1,137 patients…
Impact: As an immunotherapy pioneer and director of Meyer Cancer Center, Wolchok praised the results as an important step forward, reinforcing the scientific validity of personalized cancer vaccines.
Aug 19, 2026 · 126 articles
ERGEN INTELLIGENCE
Track Jedd Wolchok live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.